Analysis of the immune response of a new malaria vaccine based on the modification of cryptic epitopes

Parasitology Research
Yan ShenYinghui Li

Abstract

Malaria is a severe, life-threatening infectious disease that endangers human health. However, there are no vaccines or immune strategy of vaccines succeeding in both erythrocytic and pre-erythrocytic stage. During the liver stage of the Plasmodium life cycle, sporozoites invade the host liver cells. The sporozoites, then, induce a cellular immune response via the major histocompatibility complex (MHC) molecules on their surfaces. The cytotoxic T lymphocytes (CTLs) then recognize the corresponding antigen-MHC complex on the surfaces of these infected liver cells and kill them. However, dominant epitopes with high MHC affinity are prone to mutation due to immune selection pressure. CTLs evoked by the original dominant epitopes cannot recognize the mutated epitopes, leading to immune evasion. In this study, we have modified the cryptic epitopes of different antigens in the sporozoite and liver stages of Plasmodium falciparum to increase their immunogenicity without changing T cell antigen receptor (TCR)-peptide binding specificity. In addition, we have also added an important erythrocytic phase protective antigen, named apical membrane antigen 1 (AMA-1), to this process with the goal of constructing a complex multi-stage, multi-e...Continue Reading

References

Apr 4, 2002·The Journal of Infectious Diseases·Stephen L HoffmanThomas L Richie
Feb 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ann-Kristin MuellerStefan H I Kappe
May 2, 2007·Current Opinion in Infectious Diseases·Bernard N Kanoi, Thomas G Egwang
Nov 16, 2010·Annales pharmaceutiques françaises·J CohenA Leach
Mar 3, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Fatin Nawwab Al-DeenRoss Coppel
Mar 26, 2011·Trends in Parasitology·Robert J Schwenk, Thomas L Richie
Oct 20, 2011·The New England Journal of Medicine·UNKNOWN RTS,S Clinical Trials PartnershipPreeti Vansadia
Nov 10, 2012·The New England Journal of Medicine·UNKNOWN RTS,S Clinical Trials PartnershipPreeti Vansadia
Oct 12, 2013·Malaria Journal·Geoffrey A T TargettGraham V Brown
Nov 6, 2013·Parasite Immunology·J B de Souza
Mar 19, 2014·Journal of Internal Medicine·C Arama, M Troye-Blomberg
Aug 27, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Susanne H HodgsonSimon J Draper
Sep 10, 2014·International Journal for Parasitology·Denise L DoolanCarla Proietti

❮ Previous
Next ❯

Citations

Jan 13, 2017·Journal of Virology·Flavia ChiuppesiFelix Wussow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Babesiosis

Babesiosis is caused by parasites of the genus babesia, which are transmitted in nature by the bite of an infected tick. Discover the latest research on babesiosis here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.